Skip to content

Source filing unavailable

Q4 2013 · —
Revenue$220.77M+3.0% vs Q4 2012+3.5% vs Q3 2013
Net Income$13.77M+7.7% vs Q4 2012N/M vs Q3 2013
EPS Diluted$0.45−2.2% vs Q4 2012N/M vs Q3 2013
Gross Profit$136,932,000+3.3%
Operating Incomederived$63,148,000+240.3%
Operating Cash Flowderived$11,696,000N/M
Free Cash Flowderived$7,117,000N/M
Margins · derived
Gross margin62.0%+0.2 pt vs Q4 2012
Operating margin28.6%+19.9 pt vs Q4 2012
Net margin6.2%+0.3 pt vs Q4 2012

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ4 2013Q4 2012Q4 2011Q4 2010
Revenue$220.77M$214.43M$203.52M$194.13M
Net Income$13.77M$12.79M$4.56M$18.81M
EPS Diluted$0.45$0.46$0.16$0.63

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR